Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

BACKGROUND: Breast cancer is the leading cause of cancer-related mortality in women worldwide. Long non-coding RNAs (lncRNAs) are of critical importance in tumor drug resistance. Herein, this study aims to determine the roles of lncRNA ZEB1-AS1 in drug resistance of breast cancer involving microRNA-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Cell Int
Auteurs principaux: Gao, Jin, Yuan, Yuan, Zhang, Lili, Yu, Shaorong, Lu, Jianwei, Feng, Jifeng, Hu, Sainan
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Primary Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7092489/
https://ncbi.nlm.nih.gov/pubmed/32210737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-1164-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires